Preparation method and application of traditional Chinese medicine composition submicron emulsion
Through the combination of ethanol extract and specific oils of the traditional Chinese medicine composition, the submicron emulsion of the traditional Chinese medicine composition is prepared by using phacoemulsification technology, which solves the problem of slow absorption of traditional Chinese medicine dosage forms and interacts with complex ingredients, significantly improving the therapeutic effect of rheumatoid arthritis. .
Patent Information
- Application Number
- CN202411089171.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-09
- Publication Date
- 2024-11-22
AI Technical Summary
The slow absorption of traditional Chinese medicine dosage forms, low bioavailability, poor taste and inconvenient portability, limit their application and popularity in modern society, and the complex ingredients of Chinese medicine have led to increased difficulty in preparing submicromilk and quality control.
Using the ethanol extract solution of traditional Chinese medicine composition, Polygonum multiflorum essential oil, grape seed oil, ginger oil, methyl salicylate and emulsifier combination, the submicron emulsifier of traditional Chinese medicine composition is prepared through phacoemulsification and centrifugation technology to ensure the extraction of active ingredients of the medicinal material. and optimize the grouping.
It significantly improved the degree of bone and joint swelling of rats with rheumatoid arthritis, reduced the infiltration of inflammatory cells on synovial membrane and cartilage tissue, improved bone density, and significantly improved the treatment effect of rheumatoid arthritis.
Smart Images

Figure CN118986878A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of traditional Chinese medicine, and in particular to a preparation method of a submicronized traditional Chinese medicine composition and application thereof. Background Art
[0002] With the development of modern science and technology and people's growing demand for health, the combination of traditional Chinese medicine and modern science and technology has become a hot topic in research. With its unique theoretical system and rich clinical experience, Chinese medicine has shown unique advantages in treating chronic diseases and regulating physical fitness. However, traditional Chinese medicine dosage forms such as decoctions and pills have problems such as slow absorption, low bioavailability, poor taste and inconvenience in carrying, which limits its application and popularization in modern society.
[0003] As a stable nano-scale dispersion system, submicroemulsion usually has a particle size below 100 nanometers. It has ultra-microstructure, high dispersibility, strong penetration and other characteristics. It can significantly improve the solubility of drugs, enhance targeting, and promote drug penetration through biological membranes, thereby improving bioavailability and therapeutic effects. Therefore, the development of submicroemulsion preparations of traditional Chinese medicine has become an important direction for improving the efficacy of traditional Chinese medicine and improving patient compliance. Although the research on submicroemulsions of traditional Chinese medicine has made certain progress, it still faces several key technical challenges: how to efficiently extract and retain the active ingredients in traditional Chinese medicine; how to select suitable emulsifiers and co-emulsifiers to ensure the long-term stability of submicroemulsions; and how to design reasonable formulations to enhance the therapeutic effect of specific diseases. In particular, many traditional Chinese medicines have complex ingredients and may interact with each other, which brings additional difficulties to the preparation and quality control of submicroemulsions. Therefore, how to provide a submicroemulsion preparation of traditional Chinese medicine that not only maintains the traditional efficacy of traditional Chinese medicine but also has high bioavailability is of great significance to the modern application of traditional Chinese medicine. Summary of the invention
[0004] The purpose of the present invention is to provide a method for preparing a submicronized Chinese medicine composition and its application, so as to solve the problems existing in the above-mentioned prior art.
[0005] To achieve the above object, the present invention provides the following solutions:
[0006] Technical solution 1: A submicron emulsion of a Chinese medicine composition, the components of which include an ethanol extract of the Chinese medicine composition, Polygonum hydropiper essential oil, grape seed oil, ginger oil, an emulsifier, and methyl salicylate; the components of the Chinese medicine composition include Rhizoma Cyperi, Pittosporum tobira bark, Polygonum hydropiper, Herba Hemerocallis, Herba Epimedii, Zanthoxylum bungeana, Herba Hellebores and pine knot.
[0007] Furthermore, the components of the traditional Chinese medicine composition include, by weight: 10-20 parts of Radix Pseudostellariae, 13-17 parts of Cortex Pittosporume, 8-12 parts of Polygonum hydropiper, 8-12 parts of Hemiptera: Semi-arid Herba Epimedii, 8-12 parts of Epimedium, 4-6 parts of Zanthoxylum bungeanum, 4-8 parts of Helleborus chinensis and 8-12 parts of pine knotweed.
[0008] Furthermore, the components of the traditional Chinese medicine composition include, by weight: 15 parts of Radix Polygonati Sinensis, 15 parts of Cortex Pittosporum tobira, 10 parts of Polygonum hydropiper, 10 parts of Hemiptera: Semi-arid Herba Epimedii, 10 parts of Epimedium, 4 parts of Zanthoxylum bungeanum, 6 parts of Helleborus officinalis and 10 parts of pine knotweed.
[0009] Furthermore, the preparation method of the ethanol extract comprises: crushing each Chinese medicine in the Chinese medicine composition into coarse powder, adding 12 times the amount of ethanol, and soaking for 10 days, wherein the volume concentration of the ethanol is 80%.
[0010] Furthermore, the emulsifier is poloxamer.
[0011] Technical solution 2: The preparation method of the submicron emulsion of the Chinese medicine composition is as follows: after filtering the ethanol extract, diluting it with sterile distilled water to an ethanol content of 50%, mixing it with the hot polygonum odoratum essential oil at a volume ratio of 100:1 as the water phase, methyl salicylate is added to the hot polygonum odoratum essential oil, and the volume ratio of the hot polygonum odoratum essential oil: methyl salicylate is 100:1; ginger oil and grape seed oil are mixed at a volume ratio of 1:40 to obtain an oil phase; the water phase, the oil phase and the emulsifier are mixed at a volume ratio of 87:10:3, ultrasonically treated at 350w for 5min, emulsified twice under 1500bar, centrifuged at 4000r / min for 15min, and the submicron emulsion of the Chinese medicine composition is obtained without stratification.
[0012] Technical solution three: Use of the submicronized Chinese medicine composition in the preparation of a drug for treating rheumatoid arthritis in rats.
[0013] Technical Solution 4: Use of the submicronized Chinese medicine composition in the preparation of a drug for improving the degree of bone and joint swelling in rats.
[0014] Technical Solution 5: Use of the submicronized Chinese medicine composition in the preparation of a drug for restoring synovial damage in rats.
[0015] Technical Solution 6: Use of the submicronized Chinese medicine composition in the preparation of a drug for reducing the content of inflammatory factors in rat serum.
[0016] The present invention discloses the following technical effects:
[0017] The invention discloses a preparation method and application of a Chinese medicine composition submicron emulsion. All medicinal materials of the invention are selected from non-toxic natural plant resources, ensuring the high quality and environmental protection properties of the product. The Chinese medicine composition includes ethanol extracts of Radix Angelicae Pubescentis, Cortex Pittosporum, Polygonum oleifera, Herba Pinelliae, Herba Epimedii, Zanthoxylum bungeana, Fructus Hellebores and Pine. The invention effectively extracts the active ingredients in these medicinal materials through a precisely controlled ethanol extraction process. Polygonum oleifera essential oil, grape seed oil, ginger oil, methyl salicylate and emulsifier are also added to prepare a Chinese medicine composition submicron emulsion. The results show that the Chinese medicine composition submicron emulsion provided by the invention can improve the swelling degree of bone joints of rats with rheumatoid arthritis, eliminate the red and swollen state, reduce the infiltration of inflammatory cells into synovial tissue, the infiltration of inflammatory cells into cartilage tissue, and also improve the bone density of rats with rheumatoid arthritis, and has a significant therapeutic effect on rats with rheumatoid arthritis, and has a certain development and application prospect. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0019] Figure 1 The response surface diagram of the interaction between ultrasound power and ultrasound time on the particle size of compound submicron emulsion;
[0020] Figure 2 This is the response surface diagram of the effect of ultrasonic power and homogenization pressure on the particle size of compound submicroemulsion;
[0021] Figure 3 This is the response surface diagram of the effect of ultrasound time and homogenization pressure on the particle size of compound submicroemulsion;
[0022] Figure 4 The established model can be used to predict the effect of conditions on K e The impact of value size;
[0023] Figure 5 The effect of the submicronized emulsion of the Chinese medicine composition of the present invention on the ankle joints of rats with rheumatoid arthritis;
[0024] Figure 6 The effect of the submicronized emulsion of the Chinese medicine composition of the present invention on the bone and joints of rats with rheumatoid arthritis;
[0025] Figure 7 This is the effect of the submicronized emulsion of the Chinese medicine composition of the present invention on the knee joints of rats with rheumatoid arthritis (100×). DETAILED DESCRIPTION
[0026] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0027] It should be understood that the terms described in the present invention are only for describing a particular embodiment and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.
[0028] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.
[0029] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present invention description and examples are exemplary only.
[0030] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.
[0031] Example 1
[0032] 1. Preparation method of Chinese medicine composition submicron emulsion
[0033] (1) Screening and determination of Chinese medicine compositions
[0034] According to the folk application of medicinal materials and the network database, the medicinal materials with external use for the treatment of rheumatoid arthritis were screened. Weigh the powder of each medicinal material, add 12 times the amount of 80% volume concentration of ethanol, soak for 7 days, filter, add sterile distilled water to the filtrate to dilute the ethanol content to 50%, and obtain the alcohol extract of each medicinal material, which is sealed and stored for later use. The therapeutic activity of the alcohol extract of each medicinal material on rheumatoid arthritis in mice (establishment of rheumatoid arthritis mouse model: ICR mice, male, weighing 18-22g, after 1 week of adaptive feeding, the left leg is shaved, depilatory cream is used to remove hair, and 0.1ml (1mg / ml) of bovine type II collagen-incomplete Freund's adjuvant is injected).
[0035] Activity screening: On the 7th day after modeling, the mice were randomly divided into groups, with each medicinal material as one group, 10 mice in each group, and the alcohol extracts of each medicinal material prepared above were given according to the grouping, once a day, 0.5 ml each time was applied to the thigh hair removal modeling site, the swelling degree and redness of the joints were observed every day, and the circumference of the mouse joints was measured with a soft tape measure once a week, and photos were taken and recorded at the same time. On the 10th day of modeling, the mice were given an intraperitoneal injection of 0.1 mg (1 mg / ml) complete Freund's adjuvant for reinforcement. The drug was administered continuously for 8 weeks, and finally the swelling degree of the mouse joint foot circumference was used as the investigation index to judge the activity of each medicinal material. The results of the medicinal material activity screening are shown in Table 1.
[0036] Table 1
[0037] Name of medicinal material Foot circumference mm Model 19.95±1.26 Penetrating fragrant 17.63±0.89** Windproof 18.75±0.08 Poria 18.87±0.91 Cassia twig 18.75±0.1 Asarum 18.78±4.13 Polygonum hydropiper 18.03±0.36** Pittosporum bark 18.23±0.24* Half Maple 18.45±0.17* Epimedium 18.32±0.28* Sichuan peppercorn 18.34±0.31* Iron chopsticks 18.41±0.17* Turpentine 18.26±0.36*
[0038] According to the activity strength and combined with the principle of Chinese medicine compatibility, the selected active medicinal materials are Radix Angelicae Pubescentis, Pittosporum tobifolium, Polygonum oleraceum, Herba Hemerocallis, Herba Epimedii, Zanthoxylum bungeana, Helleborus chinensis and Pine Reindeer. The selected medicinal materials are formulated into prescriptions, and the prescription compatibility combinations are as follows: Formula 1: 10 parts of Radix Angelicae Pubescentis, 13 parts of Pittosporum tobifolium, 8 parts of Herba Epimedii, 4 parts of Helleborus chinensis, 8 parts of Herba Hemerocallis, 8 parts of Polygonum oleraceum, 8 parts of Pine Reindeer chinensis, 4 parts of Zanthoxylum bungeana; Formula 2: 15 parts of Radix Angelicae Pubescentis, 15 parts of Pittosporum tobifolium, 10 parts of Polygonum oleraceum, 10 parts of Herba Epimedii, 10 parts of Pine Reindeer chinensis, 10 parts of Helleborus chinensis, 4 parts of Zanthoxylum bungeana; Formula 3: 20 parts of Radix Angelicae Pubescentis, 17 parts of Pittosporum tobifolium, 12 parts of Polygonum oleraceum, 12 parts of Herba Epimedii, 12 parts of Herba Hemerocallis, 12 parts of Pine Reindeer chinensis, 8 parts of Helleborus chinensis and 6 parts of Zanthoxylum bungeana.
[0039] The results of the activity of the formulas with the best efficacy are shown in Table 2.
[0040] Table 2
[0041] Group Foot circumference mm Model 18.95±0.33 Formula 1 18.16±0.27* Formula 2 17.81±0.21** Formula 3 18.30±0.37*
[0042] The results in Table 2 show that, compared with the model group, Formula 2 has the best therapeutic activity on rheumatoid arthritis mice, and the difference is quite significant. Therefore, Formula 2 is selected as the best formula of the present invention.
[0043] (2) Optimizing the soaking preparation process of the best formula using orthogonal experiments
[0044] 1) Optimization of the process of Chinese medicine composition: The soaking days, ethanol concentration, ethanol addition multiple and particle size were used as the evaluation factors (see Table 3), and the methyl salicylate content was used as the evaluation index. Combined with the therapeutic effect on rheumatoid arthritis mice, the best formulation process was determined, and the particle size of the coarse powder was not sieved.
[0045] Table 3
[0046] Factor Level A. Soaking days B Ethanol concentration % C Ethanol addition times Particle size 1 3 70 8 Coarse powder (not sifted) 2 7 80 12 20 mesh 3 10 90 16 60 mesh
[0047] Optimization of extraction process of traditional Chinese medicine combination
[0048] The content of methyl salicylate in the best Chinese medicine composition was used as the quality inspection index of the submicroemulsion system. The content of methyl salicylate under the best process conditions was determined by HPLC (chromatographic conditions: using Phenomenex Gemini C18 (250mm×4.6mm, 5μm) chromatographic column, mobile phase: acetonitrile: methanol: water 50:5:45; detection wavelength 304nm, flow rate 1ml / min), and the measured contents are shown in Table 4. The best process L9 (4 3 )The results of orthogonal test and variance analysis are shown in Table 4 and Table 5.
[0049] Table 4
[0050]
[0051] Table 5
[0052] Sources of variation sum of squares Degrees of Freedom Mean Square F-number P-value Significance A* 3.63 2 1.83 85.93 0.01 * B 0.269 2 0.14 6.15 0.25 C 0.23 2 0.09 3.12 0.43 D 0.06 2 0.031 error 0.04 2 0.031 sum 4.229
[0053] The influence of factors on the experimental results is A>B>C>D.
[0054] The results showed that the best process was: soaking for 10 days, adding ethanol at a volume concentration of 80%, adding 12 times the amount of ethanol, and the degree of grinding the medicinal materials to coarse powder.
[0055] (3) Preparation of Polygonum hydropiper volatile oil
[0056] Weigh the medicinal material of Polygonum hydropiper, add 90% ethanol with a volume that is 10 times the weight of the medicinal material and soak it for 24 hours. After ultrasonication for 30 minutes, filter the soaking solution and add water to adjust the ethanol concentration to 50%. Load the macroporous resin and elute with 10% ethanol, then with 50% ethanol, and then with 90% ethanol. Discard 1.5 column volumes to obtain the volatile oil of Polygonum hydropiper.
[0057] (4) Process optimization conditions for submicron emulsion of traditional Chinese medicine composition
[0058] According to the response surface Box-Behnken design principle, the ke value was taken as the response value, and the three factors that had the greatest impact on the ke value of the submicron emulsion of the Chinese medicine composition in the single factor experiment, namely, ultrasonic power, ultrasonic time and homogenization pressure, were taken as the investigation factors (see Table 6).
[0059] Table 6
[0060] level Ultrasonic power A / W Ultrasonic time B / min Homogenization pressure C / (MPa) -1 250 3 500 0 350 4 1500 1 450 5 2500
[0061] (5) Optimization of the optimal preparation process conditions for submicronized emulsions of traditional Chinese medicine compositions
[0062] The test was carried out according to the set process parameters, and the test results are shown in Table 7. The test results were subjected to regression fitting analysis by Design Expert 8.0.6 software, and the regression equation was Y = 0.4582-0.0984*A-0.0155*B-0.0436*C+0.0075*AB-0.0473*AC+0.0040*BC+0.0423*A2-0.0445*B2+0.0473*C2. The optimal process conditions calculated were ultrasonic power 439.578, ultrasonic time 3.186, and homogenization pressure 2243.228, which were corrected to ultrasonic power 450W and ultrasonic time 3min. According to the instrument parameters, the homogenization pressure was set to 2000bar.
[0063] Table 7
[0064]
[0065]
[0066] Table 8
[0067] factor sum of squares Degrees of Freedom Mean Square F P Significance Model 0.1283 9 0.0143 55.61 <0.0001 *** A 0.0774 1 0.0774 302.08 <0.0001 *** B 0.0019 1 0.0019 7.5 0.029 * C 0.0152 1 0.0152 59.41 0.0001 * AB 0.0002 1 0.0002 0.8779 0.38 AC 0.0089 1 0.0089 34.84 ** BC 0.0001 1 0.0001 0.2497 A2 0.0075 1 0.0075 29.36 0.001 * B2 0.0083 1 0.0083 32.5 0.0007 ** C2 0.0094 1 0.0094 36.72 0.0005 0.0006 Residual 0.0018 7 0.0003 0.6326 Lack of Fit 0.0005 3 0.0002 0.5431 0.6783 Pure Error 0.0013 4 0.0003 sum 0.1301 16 CV% 3.34 <![CDATA[R 2 ]]> 0.9862 <![CDATA[AdjustedR 2 ]]> 0.9685 <![CDATA[PredictedR 2 ]]> 0.9208
[0068] Table 8 shows that the lack-of-fit term P = 0.6783 > 0.05, indicating that the lack-of-fit is not significant, that is, the established model can be used to predict the effect of conditions (ultrasonic power, ultrasonic time, homogenization pressure) on K e The effect of value size (see Figure 4 ). 2 =0.9685, indicating that the compound submicron emulsion K e 96.85% of the change in the value comes from the selected factors. Therefore, the order of influence of factors A, B, and C on the size of the compound submicroemulsion is: A>C>B, that is, ultrasonic power>homogenization pressure>ultrasonic time.
[0069] Under the condition that other factors remain unchanged, two interaction factors are selected to affect the K e Response surface analysis was performed on the size. Figure 1 , Figure 2 and Figure 3 The response surface diagrams are the interaction between ultrasound power and ultrasound time, ultrasound power and homogenization pressure, and ultrasound time and homogenization pressure on the particle size of compound submicron emulsion. The results show that the interaction between A and C is significant. Figure 4 This shows that the predicted value and the actual value are basically on a straight line, which means that the closer the average ratio of the predicted value to the actual value is to 1, the better the prediction effect of the model.
[0070] (5) Preparation of submicron emulsion of Chinese medicine composition
[0071] Based on the appearance of submicron emulsion, centrifugal test, centrifugal stability coefficient K e Values, etc. are used as evaluation indicators to examine the influence of each factor level on submicron emulsion. Determination of experimental conditions: The reagents with emulsifying activity are screened experimentally, and the reagents with better emulsifying effect and smaller ke are selected as the emulsifiers of the present invention, as shown in Table 9. After experimental screening, the present invention selects broxamer as the emulsifier. The screening of the mixing ratio of ginger oil and grape seed oil is shown in Table 10. After experimental screening, the optimal ratio combination of ginger oil and grape seed oil of the present invention is selected as 1:40.
[0072] Table 9
[0073]
[0074] Table 10
[0075]
[0076]
[0077] After filtering each portion of the ethanol extract in the best formula, sterile distilled water is diluted to an ethanol content of 50%, and mixed with hot polygonum odoratum essential oil at a volume ratio of 100:1 as a water phase, methyl salicylate is added to the hot polygonum odoratum essential oil, and the volume ratio of hot polygonum odoratum essential oil: methyl salicylate is 100:1; ginger oil and grape seed oil are mixed at a volume ratio of 1:40 to obtain an oil phase, and the ginger oil and grape seed oil are commercially available; the water phase, the oil phase and the emulsifier borax are mixed at a volume ratio of 87:10:3, ultrasonically treated at 350W for 5 minutes, placed in an emulsifier for emulsification at 1500bar for 2 times, centrifuged at 4000r / min for 15 minutes, and a submicron emulsion of a traditional Chinese medicine composition is obtained without stratification.
[0078] 2. Safety evaluation of submicronized Chinese medicine composition
[0079] The submicron emulsion of the Chinese medicine composition prepared according to step (5) was subjected to an acute oral experiment on mice. Method: 10 mice were gavaged with 0.8 ml of the maximum dose at one time, and 1.2 ml of the submicron emulsion of the Chinese medicine composition was given 24 hours later, and no mouse death was observed; Skin irritation experiment: The submicron emulsion of the Chinese medicine composition of the present invention was applied to the back skin of rabbits, and no biting, scratching, or redness and swelling was observed in the rabbits, indicating that the submicron emulsion of the Chinese medicine composition prepared by the present invention does not cause irritation to the skin.
[0080] 3. The therapeutic effect of Chinese medicine submicron emulsion on rheumatoid arthritis in rats
[0081] Model establishment: 60 SD rats, male, weighing 200±50g, after one week of adaptive feeding, the left thigh of the rat was shaved, and then depilatory cream was used for depilation. After anesthesia, 0.1ml incomplete Freund's adjuvant was injected into the ankle joint, and the swelling of the mouse joint was observed. After the seventh day, 0.1ml complete Freund's adjuvant was injected into the rat abdominal cavity for reinforcement. On the second day after reinforcement, 1ml of the Chinese medicine composition prepared by the present invention was applied to the rat modeling site at a low (containing 1.5mg / l of methyl salicylate), a medium (containing 3.0mg / l of methyl salicylate), and a high (containing 6.0mg / l of methyl salicylate). 1ml of far-infrared gel was selected as a positive control. The model group was given 1ml of normal saline, and the circumference of the rat ankle joint was measured every 2 days, and the swelling of the joint was observed. Photographing and recording, after 8 weeks of administration, rat X-ray was used to detect changes in ankle bone, rat serum was taken, SOD, MDA, GSH and other contents were measured, and ankle joints were taken for pathological sections such as HE. The healing of ankle synovial tissue was observed.
[0082] 4. Effect of the submicronized Chinese medicine composition of the present invention on the changes in the foot circumference of rats with rheumatoid arthritis
[0083] The rats were given the submicronized Chinese medicine composition of the present invention for 8 weeks, and the swelling of the ankle joints was improved (see Figure 5 ), the results showed that the model group rats had swollen joints, reddish-purple color, and difficulty in movement, while in the drug-treated groups, as the dose increased, the swelling of the joints of the medium and high doses was reduced, the color returned to normal, and the rats were able to move freely. The results of the changes in the circumference of the feet of rats are shown in Table 11, where the change in foot circumference = foot circumference after modeling - foot circumference before modeling. The results in Table 11 show that after modeling, the circumference of the rats' feet reached the maximum on day 27. After treatment, the ankle joints of the rats began to shrink and the circumference decreased. Compared with the model group, 21 days after drug administration, the swelling of the joints of the rats in the drug-treated group began to subside, and the change in foot circumference began to decrease, and there was a significant difference (P<0.05). After 8 weeks of treatment, the swelling of the rats subsided significantly (see Figure 5 ), the foot circumference decreased significantly compared with the model group (P<0.01), indicating that the present invention has a certain effect on reducing swelling in rats with rheumatoid arthritis.
[0084] Table 11
[0085] Group 7d(mm) 14d(mm) 21d(mm) 27d(mm) 42d(mm) 56d(mm) Model Group 6.79±0.69 9.89±1.35 10.26±1.45 12.73±1.63 12.83±1.76 11.57±2.63 Positive group 4.36±0.5* 8.83±1.26 9.33±1.52 10.37±1.89 8.94±1.24* 6.01±1.99* Low dose group 6.53±0.98 8.19±1.34 10.03±1.98 10.61±1.35 9.68±1.21* 6.51±1.27* Medium dose group 5.14±0.96 9.53±1.41 9.81±1.67 9.93±1.49 7.35±1.65** 5.06±1.32** High dose group 4.61±0.72* 8.66±1.62 8.01±1.58* 7.86±1.54* 5.31±1.58** 4.56±1.29**
[0086] Compared with the model group, * indicates P < 0.05; ** indicates P < 0.01.
[0087] 5. Effect of the submicronized Chinese medicine composition of the present invention on the imaging of the ankle joints in rats with rheumatoid arthritis
[0088] After 8 weeks of administration, X-RAY detection revealed that there was no swelling in the joint tissues of the blank rats, the joint gaps in various places were clearly visible without narrowing, and the surrounding bone density was uniform. Compared with the blank group, the gaps in the ankle joints of the rats in the model group became narrower, bone absorption and destruction were locally visible, the bone density was uneven, the soft tissues around the ankle joints were obviously swollen and developed, and obvious toe joint contractures were seen. The symptoms of the drug-treated group were significantly improved, and the dose relationship was significant. Compared with the model group, the joint gaps in the high-dose group were clear without narrowing, the bone density was uniform, the surrounding tissues were not swollen and developed, and the toe joint contractures were significantly improved, close to the blank group. This shows that the administration of the present invention can significantly improve the pathological conditions of rats with rheumatoid joints. The effect of the submicronized emulsion of the Chinese medicine composition of the present invention on the bones and joints of rats with rheumatoid arthritis is shown in Figure 6 .
[0089] 6. Effect of the submicronized Chinese medicine composition of the present invention on HE of bone and joint tissues in rats with rheumatoid arthritis
[0090] The ankle joint structure of the blank group was normal, the joint space was equal, the joint surface was smooth, there was no inflammatory cell infiltration, no exfoliation, no synovial hyperplasia and hypertrophy, and pannus formation, and the articular cartilage and bone were intact. The ankle joint structure of the model group rats was abnormal, the cartilage surface and bone were severely damaged, and there was no complete morphology. As shown by the arrow, the surface was not smooth, the cartilage surface cells were degenerated and necrotic, the surface was exfoliated, the trabeculae were arranged in disorder, the synovial hyperplasia was hypertrophic, a large number of inflammatory cells infiltrated, and the articular cartilage and bone continuity disappeared. After the treatment of the present invention, the ankle joint structure of the rats was significantly improved, and the low-level damage was obvious, but compared with the model group, the degree of damage was lighter, the surface smoothness was better than the model group, the cartilage was clearly visible, and a small amount of inflammatory cells infiltrated the synovium, while the cartilage surface of the medium and high dose groups was smooth, there was no inflammatory cell infiltration, and there was no inflammatory cell infiltration in the synovial tissue, the joint continuity was good, and its recovery was close to the blank group. It shows that the present invention can significantly improve the damage of rheumatoid arthritis rats and inhibit the damage of inflammatory cells to nostalgia and joints. Effect of the present invention on HE staining of pathological sections of knee joints of rats with rheumatoid arthritis (100×) Figure 7 .
[0091] 7. Effect of the submicronized Chinese medicine composition of the present invention on inflammatory factors in the serum of rats with rheumatoid arthritis
[0092] The cytokines in the rat serum were measured (see Table 12), and it was found that the submicron emulsion of the Chinese medicine composition of the present invention can increase the content of SOD in rat serum, reduce the content of MDA and NO oxidative factors, and reduce the content of inflammatory factor IL-17. The model group was compared with the blank group, and the difference was significant (P<0.05 or P<0.01), indicating that the modeling was successful. The drug administration group was compared with the model group, and the difference was more significant (P<0.05 or P<0.01), indicating that the submicron emulsion of the Chinese medicine composition of the present invention can increase the SOD content in rats with rheumatoid arthritis, remove the content of oxidative factors such as MDA and NO, remove the content of IL-17, and promote the recovery of rat arthritis.
[0093] Table 12
[0094] Group SOD (U / ml) MDA (nmol / ml) NO(nmol / ml) IL-17 (pg / ml) Blank group 728.16±67.93 5.27±0.63 0.53±0.27 10.51±2.74 Model Group 517.35±47.86# 7.89±0.87# 8.31±1.56## 16.37±1.64# Positive control group 689.79±57.51* 5.61±0.45* 2.51±0.42** 12.25±1.14* Low dose group 612.48±64.18* 6.18±0.75 4.96±0.66* 15.87±1.36 Medium dose group 718.11±87.14** 5.45±0.48* 2.61±0.87** 13.27±1.19* High dose group 723.68±71.62** 4.89±0.69* 2.09±0.36** 11.78±1.43**
[0095] Compared with the model group, * indicates P < 0.05; ** indicates P < 0.01; compared with the blank group, # indicates P < 0.05; ## indicates P < 0.01.
[0096] The above results show that the submicronized emulsion of the Chinese medicine composition of the present invention improves the content of superoxidase SOD in the serum of rats with rheumatoid arthritis at the biochemical level, reduces the content of oxidative factors such as MDA and NO, increases the antioxidant capacity of rats, removes the content of inflammatory factors, and has a certain anti-inflammatory function. In summary, the submicronized emulsion of the Chinese medicine composition of the present invention improves the swelling degree of rat bone joints, eliminates the red and swollen state, reduces the infiltration of inflammatory cells into synovial tissue, the infiltration of inflammatory cells into cartilage tissue, and also improves the bone density of rats with rheumatoid arthritis, has a significant therapeutic effect on rats with rheumatoid arthritis, and has a certain development and application prospect.
[0097] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.
Claims
1. A Chinese medicine composition submicron emulsion, characterized in that: The components include ethanol extract of a traditional Chinese medicine composition, essential oil of hot polygonum, grape seed oil, ginger oil, emulsifier, and methyl salicylate; the components of the traditional Chinese medicine composition include osmanthus fragrans, sea cucumber bark, hot polygonum fragrans, half-blossom lotus, epimedium, Zanthoxylum bungeanum, helleborus chinensis and pine knot.
2. The Chinese medicine composition submicron emulsion according to claim 1, characterized in that: The components of the traditional Chinese medicine composition include, by weight, 10-20 parts of Radix Pseudostellariae, 13-17 parts of Cortex Pittosporume, 8-12 parts of Polygonum hydropiper, 8-12 parts of Hemiptera: Semi-arid Herba Epimedii, 8-12 parts of Epimedium, 4-6 parts of Zanthoxylum bungeanum, 4-8 parts of Helleborus chinensis and 8-12 parts of pine knotweed.
3. The Chinese medicine composition submicron emulsion according to claim 2, characterized in that: Calculated by weight, the components of the traditional Chinese medicine composition include: 15 parts of Radix Tobiko, 15 parts of Cortex Pittosporum, 10 parts of Polygonum hydropiper, 10 parts of Hemiptera: Semi-arid Herba, 10 parts of Epimedium, 4 parts of Zanthoxylum bungeanum, 6 parts of Helleborus officinalis and 10 parts of pine knot.
4. The Chinese medicine composition submicron emulsion according to claim 1, characterized in that: The preparation method of the ethanol extract comprises: crushing each Chinese medicine in the Chinese medicine composition into coarse powder, adding 12 times the amount of ethanol, and soaking for 10 days, wherein the volume concentration of the ethanol is 80%.
5. The Chinese medicine composition submicron emulsion according to claim 1, characterized in that: The emulsifier is poloxamer.
6. The method for preparing the submicronized emulsion of the Chinese medicine composition according to claim 1, characterized in that: After filtering the ethanol extract, sterile distilled water is diluted to an ethanol content of 50%, and the extract is mixed with the hot polygonum odoratum essential oil at a volume ratio of 100:1 as an aqueous phase, methyl salicylate is added to the hot polygonum odoratum essential oil, and the volume ratio of the hot polygonum odoratum essential oil to methyl salicylate is 100:1; ginger oil and grape seed oil are mixed at a volume ratio of 1:40 to obtain an oil phase; the aqueous phase, the oil phase and the emulsifier are mixed at a volume ratio of 87:10:3, ultrasonically treated at 350w for 5min, emulsified twice at 1500bar, centrifuged at 4000r / min for 15min, and the submicron emulsion of the traditional Chinese medicine composition is obtained without stratification.
7. Use of the Chinese medicine composition submicron emulsion according to any one of claims 1 to 5 in the preparation of a medicament for treating rheumatoid arthritis in rats.
8. Use of the Chinese medicine composition submicron emulsion according to any one of claims 1 to 5 in the preparation of a medicament for improving the degree of bone and joint swelling in rats.
9. Use of the Chinese medicine composition submicron emulsion according to any one of claims 1 to 5 in preparing a medicine for restoring synovial membrane damage in rats.
10. Use of the Chinese medicine composition submicron emulsion according to any one of claims 1 to 5 in the preparation of a drug for reducing the content of inflammatory factors in rat serum.
